Debrisoquin hydroxylation polymorphism was studied in 326 unrelated he
althy Turkish volunteers. Debrisoquin sulfate (10 mg) was administered
to subjects, and debrisoquin and 4-hydroxydebrisoquin were determined
in the 0- to 8-hour urine samples. Debrisoquin oxidation was polymorp
hic, with 11 subjects (3.37%; 95% confidence interval, 1.69% to 6.07%)
phenotyped as poor metabolizers. The metabolic ratio between debrisoq
uin and 4-hydroxydebrisoquine in 8-hour urine samples ranged from 0.02
in extensive metabolizers to 263.8 in poor metabolizers. The proporti
on of poor metabolizers was found to be in the range observed in the o
ther white populations studied.